JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
$189.08
+4.07 (+2.20%)
Performance
1D
—
1W
—
1M
—
3M
+10.91%
6M
+46.55%
1Y
+44.47%
YTD
+9.20%
Open$186.71
Previous Close$185.01
Day High$189.40
Day Low$186.00
52W High$182.99
52W Low$95.49
Volume—
Avg Volume704.8K
Market Cap10.27B
P/E Ratio—
EPS$-6.07
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$167.39
Above
SMA 200
$136.05
Above
RSI (14)
68.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-1.5% upside
Current
$189.08
$189.08
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.73B | 3.41B | 1.73B |
| Net Income | 514.09M | 422.31M | 500.28M |
| Profit Margin | 13.8% | 13.1% | 28.9% |
| EBITDA | 1.23B | 1.07B | 730.31M |
| Free Cash Flow | — | — | 376.40M |
| Rev Growth | +9.6% | +9.6% | +7.8% |
| Debt/Equity | 1.49 | 1.49 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |